Caffeine Caffeine What it is: Caffeine is a nervous system stimulant
Research presented at the 2025 European Association for the Study of Diabetes meeting confirmed that semaglutide users report significantly fewer obsessive thoughts about food
To avoid any confusion, lets clear up some vocabulary before we go further
QL Biopharm Completes Dosing of First Patient in HORIZON-1, a Phase 3 Trial for Weight Loss with Zovaglutide, a Once-Monthly GLP-1 RA Peptide BEIJING, China, January 19, 2026 On January 16, 2026, Beijing QL Biopharmaceutical Co, Ltd (QL Biopharm) dosed the first patient in its Phase 3 clinical trial, HORIZON-1, which will evaluate QL Biopharms ultra-long-acting GLP-1 receptor agonist (GLP-1 RA), zovaglutide (ZT002)
[5] Additionally, GLP-1 receptor agonists carry risks of gallbladder disease (cholelithiasis, cholecystitis) and pancreatitis that may present with abdominal pain and other gastrointestinal symptoms
Schedule a consultation with DripGym today to explore our peptide-based programs